Patanjali Under Scrutiny: Arrest Warrants Issued Against Baba Ramdev and Acharya Balkrishna

Patanjali Ayurved, a prominent name in the Indian wellness and FMCG industry, is embroiled in controversy as a court in Haridwar has issued a bailable arrest warrant against its founder Baba Ramdev, CEO Acharya Balkrishna and Divya Pharmacy. The charges stem from allegations of misleading advertisements promoting their products as cures for ailments such as diabetes and Covid-19, a violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The controversy escalated after repeated claims from the company that certain Ayurvedic remedies could cure severe medical conditions, a stance widely criticized by the medical community and regulatory bodies. These advertisements allegedly lacked scientific validation, raising questions about the company’s accountability and ethical practices. Despite multiple summons, Baba Ramdev, Acharya Balkrishna and Divya Pharmacy failed to appear before the court, prompting legal action.

Patanjali, often lauded for its role in reviving traditional Indian medicine, now faces significant backlash as its reputation is under scrutiny. The case highlights the growing concern over unchecked claims in the health and wellness sector. While the warrants are bailable, this legal development marks a turning point for the company, potentially impacting its public image and market credibility.